go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Oklahoma rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $2,291 · 10th–90th $2,239$4,1690%50%10th90th$2,291Professionalmedian $3,467 · 10th–90th $2,239$4,1690%20%10th90th$3,467$1.0K$2.0K$5.0K$10.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,238.72
Median
$2,290.87
Typical High
$3,890.45
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,238.72
Median
$3,467.37
Typical High
$3,801.89
Cigna
Setting
Facility
Modifier
Global
Typical Low
$5,248.07
Median
$5,248.07
Typical High
$5,248.07
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
Medica
Setting
Facility
Modifier
Global
Typical Low
$794.33
Median
$2,630.27
Typical High
$7,943.28
Medica
Setting
Professional
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$5,128.61
United
Setting
Facility
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$6,760.83
United
Setting
Professional
Modifier
Global
Typical Low
$4,073.80
Median
$4,168.69
Typical High
$4,466.84